• Featured Product
  • KD/KO Validated

PTPRE Polyclonal antibody

PTPRE Polyclonal Antibody for WB, IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IHC, ELISA

Conjugate

Unconjugated

Cat no : 13922-1-AP

Synonyms

HPTPE, PTPE, PTPRE, R PTP EPSILON



Tested Applications

Positive WB detected inHL-60 cells
Positive IHC detected inhuman breast cancer tissue, human liver tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:200-1:1000
Immunohistochemistry (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

13922-1-AP targets PTPRE in WB, IHC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen PTPRE fusion protein Ag4932
Full Name protein tyrosine phosphatase, receptor type, E
Calculated Molecular Weight 81 kDa
Observed Molecular Weight 81 kDa
GenBank Accession NumberBC050062
Gene Symbol PTPRE
Gene ID (NCBI) 5791
RRIDAB_2174672
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for PTPRE antibody 13922-1-APDownload protocol
IHC protocol for PTPRE antibody 13922-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Front Oncol

miR-631 Inhibits Intrahepatic Metastasis of Hepatocellular Carcinoma by Targeting PTPRE.

Authors - Bingqing Chen
  • KD Validated
humanIHC

Biomed Pharmacother

Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma

Authors - Renshun Dong